Navigation Links
OpenQ Announces the Release of openIIS 2.5
Date:5/27/2010

Latest Version of openQ’s software for Investigator Initiated Studies Offers Expanded Features for Compliance and Effectiveness.

Charlottesville, VA, San Francisco, CA, New York, NY and Paris, France (PRWEB) May 27, 2010 -- Building on their previous releases, openQ has released an expanded offering for managing Investigator Initiated Studies/ Trials (IIS/IIT). openIIS 2.5 provides a broad set of tools to manage the complete IIS lifecycle, from study submission and internal review, to study closeout.

openIIS is designed from the ground up to support regulatory compliance in an era of increasing federal scrutiny. Transparent customer business processes, through clearly documented and extensive audit trails, provide customers with complete access to decision criteria - including who reviewed the application, when they reviewed it, and why they made their decision. Expanded reporting functionally provides insight into studies, supporting critical areas such as financial controls.

While openIIS comes pre-configured with best practices gleaned from openQ’s industry experience, this doesn’t mean that customers are forced into a constrictive environment. The system also provides a configurable workflow engine to give customers the flexibility to configure the software to match their standard operating procedures.

“Despite its broad feature set and business process flexibility, we wanted to make openIIS easy to use,” said Matt Prentis, Director of Product Management at openQ. “Leveraging easily accessible portals for external investigators and internal users, along with submission wizards to guide investigators as they navigate the submission process help provide a smooth user experience. Additionally, key functionality to support multi-company sponsored grants simplifies even the more complex management tasks.”

openIIS is part of a broad portfolio of software and data offerings that openQ provides to Life Sciences companies. openQ provides solutions in KOL Management, Medical Affairs Programs, Grant Funding & Study Management, and Speaker Programs.

About openQ:
Based in Charlottesville, Virginia, openQ helps Life Sciences companies manage compliant business processes in their Marketing and Medical Affairs organizations. openQ’s solutions currently support compliance initiatives at 8 of the Top 10 Pharmaceutical and 3 of the Top 5 Medical Device Companies. For more information, visit openq.com.

###

Read the full story at http://www.prweb.com/releases/openQ/openIIS_Release/prweb4057984.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Direct Selling Reps' Association Announces 2010 Certificate Of Excellence Recipients
2. Dorland Health Announces People Awards Honoring Excellence & Dedication Among Healthcare Professionals - Call For Entries
3. 2 BigHearts Board Announces Addition to Board of Directors: Michael Unetich
4. George Carter of Carter's Plumbing & Rooter Announces the Launch of His New Website, CartersPlumbingRedondoBeach.com
5. The Hoppen Group Announces Partnership with SnapComms Tools
6. Jolly Announces the Release of ID Flow 5.0
7. Golden Age Resources, Inc. Announces Strategic Alliance with JK Development of Palm Beach County LLC in an Attempt to Stop the Oil Leak in the Gulf
8. Hospital Focus 5 Announces Contract with Connecticut Hospital to Improve Quality, Productivity and Cost-Effectiveness
9. Nature's Aide Vitamins, Inc. Announces a New Science Driven Osteo-Guard Vitamin Formula Designed to Quickly and Safely Halt Bone Deterioration
10. Massage Envy Announces Franchisee of the Year
11. PHD Virtual Technologies Announces Citrix Investment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
OpenQ Announces the Release of openIIS 2.5 
(Date:4/29/2016)... ... April 29, 2016 , ... A new study by a ... diaphragmatic hernia have better survival rates if surgery is performed early. Approximately one ... the diaphragm fails to form completely, letting abdominal organs into the chest cavity ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... team BioCellection won the $30,000 Perlman Grand Prize of the 2016 Wharton Business ... Award, the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow ...
(Date:4/29/2016)... NY (PRWEB) , ... April 29, 2016 , ... ... and engineer of patented products, announces the Gyrociser, an exercise invention which aids ... worth $2 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... ... ... is the deadliest type of skin cancer. Although only about 1 percent of skin cancer ... than 10,000 people are expected to die of melanoma this year. The risk increases with ... the most commonly diagnosed cancers in young women. A recent breakthrough in genetic studies may ...
(Date:4/29/2016)... , ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon ... is a very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to ... is a procedure that involves one or both jaw bones. This surgery is performed to ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016  Marking its one ... breast and ovarian cancer risk test, Color ... 30 genes that highly impact the most common ... today, the Color Test analyzes hereditary cancer risks ... and uterine cancers. The Color Test is physician ...
(Date:4/28/2016)... Dr. Vivek Ahuja , ... Ste phen Schmidt Join the ... software solutions for life sciences, today announced key new leaders have ... insight to a growing business.  This will bolster the company,s safety ... joined ArisGlobal in the position of Vice President - Safety. ...
(Date:4/28/2016)... India , April 28, 2016 ... Pipeline Review, H1 2016" is a report that ... and helps strengthen R&D pipelines by identifying new ... products. Company Profiles discussed in this ... Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma ...
Breaking Medicine Technology: